Oramed Pharmaceuticals (Israel) Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Oramed Pharmaceuticals is traded on Tel Aviv Stock Exchange in Israel. more
NameOramed Pharmaceuticals
President CEO, DirectorNadav KidronView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address142 West 57th Street
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Phone844 967 2633
Next Fiscal Year EndAugust 31, 2020
Most Recent QuarterNovember 30, 2018
Last Fiscal Year EndAugust 31, 2018

Oramed Pharmaceuticals Directors

Oramed Pharmaceuticals Corporate Directors

Miriam Kidron Chief Scientific Officer, Director
David Slager Independent Director
Aviad Friedman Independent Director
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com